隆盛科技(300680.SZ):實控人自願延長限售股鎖定期
格隆匯4月10日丨隆盛科技(300680.SZ)公佈,公司於近日收到控股股東、實際控制人倪茂生、倪銘的《關於自願延長限售股鎖定期的承諾函》。具體情況如下:
基於對公司未來發展的信心和公司價值的認可,本着對中小股東負責的態度,公司控股股東、實際控制人倪茂生、倪銘承諾,自願將各自所持有的公司首次公開發行限售股2078.66萬股、692.15萬股自2020年7月24日限售期滿之日起延長鎖定期6個月,至2021年1月23日。鎖定期內將不以任何方式轉讓或減持所持有的該部分公司股票,如因公司實施送紅股、資本公積金轉增股本等原因而增加的股份,亦應遵守上述鎖定期限的約定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.